Performance of the Empower Comprehensive Hereditary Cancer Test
Read More
Whitepaper
Resources in this stream include all of the Whitepapers.
-
-
Impact of Number of Variants in WES-based MRD Assays
Read More
-
Analytical validation of the Altera tumor genomic profiling test
Read More
-
Performance of the Empower Hereditary Cancer Test
Read More
-
Detecting molecular residual disease with Signatera
Design and analytical validation of SignateraTM, the first ctDNA assay custom-built for detecting MRD and assessing treatment response.
Read More
